Wellington Mgmt Amends United Therapeutics Stake on Dec 29

Ticker: UTHR · Form: SC 13G/A · Filed: Feb 8, 2024

Complexity: simple

Sentiment: neutral

Topics: institutional-ownership, amendment, passive-investing

TL;DR

**Wellington Management Group LLP updated its passive stake in United Therapeutics Corp.**

AI Summary

Wellington Management Group LLP filed an amended SC 13G/A on February 8, 2024, indicating a change in their ownership of United Therapeutics Corp's common stock as of December 29, 2023. This filing, an amendment to their previous disclosures, signals that Wellington Management Group LLP continues to hold a significant, but potentially adjusted, passive stake in the pharmaceutical company. For investors, this matters because large institutional holdings can influence stock stability and signal confidence (or lack thereof) in the company's long-term prospects.

Why It Matters

This filing shows that a major institutional investor, Wellington Management Group LLP, has updated its passive ownership position in United Therapeutics Corp, which can impact market perception and trading activity.

Risk Assessment

Risk Level: low — This is a routine amendment by a passive institutional investor and does not indicate any immediate or significant risk to the company or its shareholders.

Analyst Insight

A smart investor would note Wellington Management Group LLP's continued, albeit adjusted, passive stake in United Therapeutics Corp as a sign of ongoing institutional interest, but would await further details on the exact percentage change in ownership to assess its significance.

Key Players & Entities

FAQ

What type of filing is this document?

This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, indicating a change in beneficial ownership by a passive investor.

Who is the reporting person in this filing?

The reporting person is Wellington Management Group LLP, located at 280 Congress Street, Boston, MA.

What is the subject company whose securities are being reported?

The subject company is UNITED THERAPEUTICS Corp, with a business address at 1000 Spring St, Silver Spring, MD.

What is the CUSIP number for the class of securities reported?

The CUSIP number for the Common Stock of United Therapeutics Corp is 91307C102.

What was the date of the event that required this filing?

The date of the event which required the filing of this statement was December 29, 2023.

Filing Stats: 1,964 words · 8 min read · ~7 pages · Grade level 9.9 · Accepted 2024-02-08 10:18:47

Filing Documents

From the Filing

SC 13G/A 1 SEC13G_Filing.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2 ) * UNITED THERAPEUTICS Corp (Name of Issuer) Common Stock (Title of Class of Securities) 91307C102 (CUSIP Number) December 29, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 (the "Act") or otherwise subject to the liabilities of that section of the Act, but shall be subject to all other provisions of the Act (however, see the Notes.) CUSIP No. 91307C102 1. NAMES OF REPORTING PERSONS Wellington Management Group LLP 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Massachusetts NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 3,304,591 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 3,794,010 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,794,010 10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 8.07% 12. TYPE OF REPORTING PERSON HC CUSIP No. 91307C102 1. NAMES OF REPORTING PERSONS Wellington Group Holdings LLP 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 3,304,591 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 3,794,010 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,794,010 10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 8.07% 12. TYPE OF REPORTING PERSON HC CUSIP No. 91307C102 1. NAMES OF REPORTING PERSONS Wellington Investment Advisors Holdings LLP 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 3,304,591 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 3,794,010 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,794,010 10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 8.07% 12. TYPE OF REPORTING PERSON HC CUSIP No. 91307C102 1. NAMES OF REPORTING PERSONS Wellington Management Company LLP 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 2,965,754 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 3,195,591 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,195,591 10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 6.80% 12. TYPE OF REPORTING PERSON IA Item 1. (a) Name of Issuer UNITED THERAPEUTICS Corp (b) Address of Issuer's Principal Executive Offices 1000 Spring Street Silver Spring, MD 20910 Item 2. (a) Name of Person Filing Wellington Management Group LLP Wellington Group Holdings LLP Wellington Investment Advisors Holdings LLP Wellington Management Company LLP (b) Address of Principal Business Office or, if None, Residence c/o Wellington Management Company LLP 280 Congress Street Boston, MA 02210 (c) Citizenship Wellington Management Group LLP - Massachusetts Wellington Group Holdings LLP - Delaware Wellington Investment Advisors Holdings LLP - Delaware Wellington Management Company LLP - Delaware (d) Title of Class of Securities Common Stock (e) CUSIP Number 91307C102 Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a: (a) [ ] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o). (b) [ ] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c). (c) [ ] Insurance Company as defined in

View on Read The Filing